Yesterday we exposed the sheer greed and reward for failure of Neil Woodford, trousering a small fortune for just one year’s work, as investors in his funds lost a packet. Today the deadwood press have followed up and have swallowed bullshit without question. It is a sad sight and shows why the MSM is not fit for purpose.

A late in the day (4:07pm) “Trading Update” from Premier Veterinary Group (PVG). Uh oh…

In this bonus podcast, recorded at a Motorway service station, I look at the Anglo African Oil & Gas (AAOG) debacle and THREE massive failings by the Nomad and broker FinnCrap (FCAP). I raise questions about FinnCap it cannot answer but also show why this eiposde flags up the conflict of interest issue which is the cancer destroying the whole of AIM. The home truths will make uncomfortable listening for many.

I might be hopelessly optimistic with AIM-listed Sosandar (SOS), but the latest trading statement read rather well to me. As per HERE my best case scenario was for Q3 sales of £1.7 million and they came in at £1.6 million, which means that Sosandar has clocked up £3.44 million of sales in the first nine months of the year. Compared to the house broker forecast by Shore Capital of £3.9 million of revenues for the full year that, as I have previously suggested, means an easy target. It is always nice to see under-promising and over-delivering, even if I thought the targets were too easy in the first place...

Hello Share Trouncers. About two years ago, I sold this family’s shares in Ashtead (AHT). After consulting this very website, I could not see how its meteoric rise could be sustained. We took a big profit. But then, as so often happens to shares which seem overvalued, the share price continued to soar. But while I suffered many months of kicking myself, the share price then did what it should have done all along and crashed back to 1800p - the price at which I sold the lot. Then it fell even more...

In today's podcast I start with the shocking revelations about Neil Woodford's greed and reward for failure. Folks like Nomates are more of a threat to capitalism than Lenin. I am vindicated on Anglo African Oil & Gas (AAOG) and await apologies from the Bulletin Board Morons. I discuss the whole affair including the shameless behaviuour of FinnCap (FCAP). Truly FinnCrap is a moral sewer. I discuss First Derivatives (FDP), offer up my nap buy for Q1 2019 and have some questions that require an urgent answer from John Gunn's Octagonal (OCT) 

A trading statement from Topps Tiles (TPT) includes “our strategy of ‘out specialising the specialists’ continues to serve us well” and “we continue to make good progress with our plans for commercial and our strategy of ‘disrupt and construct’ is proving successful”. However, a sub 65p share price compares to more than 90p in early 2018…

Back in early December I wrote a piece warning people not to get taken in by RNS-Reach announcements, and criticising the way that some companies seemed to use the system to try to attract investors and pump their share price, by releasing information that isn’t considered to be price sensitive, but making out that it is some sort of big deal.

As this morning’s shock revelations about Neil Woodford’s greed and reward for abject failure start to sink in, I imagine that many investors in his funds will be feeling a deep sense of disgust and regret. Perhaps they will blame those who advised them to invest and who, as the performance has gone from bad to worse, to even worse, have told them to hang on or average down.  Perhaps the biggest cheerleader has been Hargreaves Lansdown which has just published another blow job type piece on Woodford.

Another day, another bunch of trading updates to review…

Thanks to Drunken Sailor for his scientific study of Bulletin Board Moron behaviour which he posted in the comments section last night in the wake of the Anglo African Oil & Gas (AAOG) hornets nest. His research is invaluable and merits a wider audience. The great man writes:

Neil Woodford’s Woodford Investment Management results for the year to to March 31 2018 have finally been released. The good news is they were filed on time – they were received by Companies House on Christmas Eve. The bad news is that over the period his equity income fund lost around 13.5% for his unit holders whilst the FTSE All-Share was broadly flat. And the shocker? Read on! This is the unacceptable face of capitalism, monstrous greed, as failure is rewarded...

Last week I noted “Appointment of Joint Broker” by Eagle Eye Solutions (EYE). Now a “Director/PDMR Shareholding” announcement…

Union Jack Oil (UJO) “is pleased to announce the commencement of drilling operations at Biscathorpe-2”…

Hello, Share Grabbers. Well, the New Year has bumped off to a decent start after a disastrous end to 2018. All the fears about a no-deal Brexit seem to have been priced in now. And some better news about the affair should send shares upwards fast. But, of course, some companies will continue to do better than others...

If you are a shareholder in OptiBiotix, Sosandar, SkinBioTherapeutics, Yourgene, Concepta or Big Sofa then put 21st January in your diary now! That evening, the man who listed all those companies and who is still involved with or close to all, will be quizzed at the next UK Investor City Forum at PwC in the City of London. Places are limited to just 90 and are first come first served. You can book a free seat HERE.

Following on from yesterday's bearcast I discuss the noise and the silence surrounding Anglo African Oil & Gas (AAOG). I look at ITM Power (ITM), Cabot Energy (CAB), Starcom (STAR), Quadrise Fuels (QFI), IQE (IQE), Accrol (ACRL), uber-smelly Independent Oil & Gas (IOG) and Footasylum (FOOT)

In September, previously writing on Footasylum (FOOT) it was our warnings prove sage as now tripping up badly. Today a “Trading Statement”…

OptiBiotix Health (OPTI) has announced that it has entered into an exclusive manufacturing and supply agreement with Zeon Lifesciences. The agreement grants Zeon an exclusive license to manufacture and supply OptiBiotix's SlimBiome weight management technology in India, in return for 50% of the profit...

In November 2017, I noted on Accrol (ACRL) bailout fundraising… at half of IPO price of only 17 months ago!. That was at 50p per share – but there was still much worse to follow. The shares had recovered from lows to a recent more than 20p – but that was before today a “Trading Update”…